All News

The provision of patient-centered care leads to better engagement between patients and their healthcare teams. One way to encourage patient-centered care is to incorporate patient-reported outcomes into clinical settings.

Using prophylaxis with biosimilar granulocyte colony-stimulating factor can reduce the severity of neutropenia in patients with soft tissue sarcoma.

What we're reading, September 19, 2016: the government update rules on reporting clinical trial findings; hospitals say they aren't receiving discounts for Valeant's heart drugs; and the FDA approved the first treatment for Duchenne muscular dystrophy.

A new national study of adults with commercial health insurance found that although use of what are termed “low-value” medical services is modest, there is potential for considerable cost savings if spending on these services is reduced.

Accountable care organizations are becoming increasingly common in the United States, but they are more likely to be formed in regions of the country with populations that have a higher socioeconomic status.

About 4 million patients need home-based medical care because they are frail, functionally limited, and homebound. New research finds out just how much are the home-based medical care providers geographically concentrated or spread out.

This week, the top managed care stories included news that Risa Lavizzo-Mourey, MD, MBA, will be leaving the Robert Wood Johnson Foundation, a report that obesity rate in the military are also on the rise, and CMS denied Ohio's proposal to charge fees for Medicaid.

Massachusetts achieved near-universal insurance coverage after enacting its own healthcare reform 10 years ago, but gains in improved access to and affordability of care faded over time.

Results for Novo Nordisk’s semaglutide were reported today at the European Association for the Study of Diabetes. A filing for FDA approval is expected before the end of the year.

The American Journal of Managed Care reached out to Daniel F. Hayes, MD, FASCO, 2016-2017 president of the American Society of Clinical Oncology (ASCO), to understand his perception of how the recommendations of the Cancer Moonshot initiative's Blue Ribbon Panel would impact cancer care in the United States.

The report showed a strong connection between states with high rates of inactivity and those with the highest rates of obesity.

Highlights of our peer-reviewed research in the healthcare and mainstream press.

The current issue of Evidence-Based Diabetes Management explores studies and patient access issues surrounding this closely watched inhaled insulin.

Patients with a history of cancer were more likely to suffer from obesity than the general population. This incidence was even greater in patients who were survivors of colorectal and breast cancers.

What we're reading, September 16, 2016: Donald Trump mentions using Medicaid to expand coverage and making birth control available without a prescription; medical marijuana could curb the opioid epidemic; and how rare diseases are becoming more common.

There has been a steady decline in death rates among children and adolescent patients diagnosed with cancer (ages 1 to 19 years), minus gender or racial disparity, between 1999 and 2014, according to a new report from the National Center for Health Statistics.

Understanding patients’ capability for self-management is a key part of understanding the risk of health declines and avoidable utilization, researchers determine.

The suit doesn't address whether soda taxes have any effect on obesity or public health, but instead hinges on finer points of Pennsylvania tax law and its constitution.

Pfizer and Merck plan to file new drug applications with FDA for the SGLT2 inhibitor by the end of the year. One combination would pair ertugliflozin with Januvia, the blockbuster DPP-4 inhibitor.

Health record banks offer a promising future for health records and secure information exchange.

Following an FDA advisory on ovarian cancer screening tests, London-based Abcodia has announced that it will temporarily stop sales of its Risk of Ovarian Cancer Algorithm test in the United States.

What we're reading, September 15, 2016: A United Nations panel challenges the market-based approach to drug research and development; an FDA panel recommends removing a serious health warning from Chantix's label; and older patients may want to wait to get their flu shot.

A cost-effectiveness analysis has found that Oncotype DX may not be economical to make clinical decisions on adjuvant radiation treatment in patients with DCIS.

An effort by the University of Utah health system created an "opportunity index" to identify areas of cost variability that would show physicians where they could find savings and improve quality.

A study published in JAMA Oncology has found that interventions to improve patient-centered communication was successful in patients with advanced cancer, but it failed to improve quality of life (QOL), patient-physician relation, or healthcare utilization toward the end of life.

The authors said this is the first study to examine antihypertension nonadherence down to the county level. Recommendations include greater use of combination therapy to reduce pill counts for patients with multiple chronic conditions, and synchronizing pharmacy visits to avoid multiple trips.

What we're reading, September 14, 2016: CMS denies Ohio's proposal to charge Medicaid fees; steep costs of healthcare continue to push Americans into poverty; and Canada approves prescription heroin to treat severe addiction.

Gaps in the treatment of depression exist with many people who screen positive for depression not receiving treatment, according to a study published in JAMA Internal Medicine.

Risa Lavizzo-Mourey, MD, MBA, is stepping down as president and CEO of the Robert Wood Johnson Foundation (RWJF) after 14 years in charge. As of yet, no successor has been named.

Between individuals coming in and out of the market in a given year and those who switch plans, the majority of people in exchanges are enrolled in their plans for one year or less.